arrow_back Back Filing freshness 10-Q Q3 FY2026 SEC EDGAR

InnovAge Holding Corp.

INNV
$11.18 ▲ +0.23 (+2.05%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
27 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Bearish
auto_awesome

Analytical Summary

InnovAge Holding Corp. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.5B
Dividend Yield
Revenue Growth 15.5%
Op. Margin -11.5%
ROIC -8.1%
FCF / Share $0.11
Trailing P/E
Price / Book 6.6x
FCF Yield 1.0%
Debt / Equity 0.24
info Valuation on last close. End-of-day price, Aug 7, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$251.94M
↑ +15.5%
Net Income Profit after all expenses
$-29.46M
↓ -158.9%
Operating Margin Operating profit as % of sales
-11.5%
↓ -308.6% 22th
FCF / Share Free cash flow per share
$0.11
↓ -23.5%
Long-Term Debt Long-term obligations
$55.43M
↓ -1.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
27
Returns
32
Financial Health
51
Cash Quality
11

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 27 quarters